Boehringer Ingelheim

Boehringer, Zealand’s GLP-1 MASH Data ‘Unintentionally’ Published by Medical Congress Website
BioSpace
Thu, 06/6/24 - 11:48 am
Zealand Pharma
Boehringer Ingelheim
MASH
survodutide
clinical trials
Top ten biopharma R&D deals of 2024
Nature
Wed, 06/5/24 - 11:24 am
R&D
Novartis
Argo Biopharmaceutical
Roche
MOMA Therapeutics
Boehringer Ingelheim
Suzhou Ribo Life Science
Eli Lilly
Isomorphic Labs
Merus
Gilead Sciences
Novo Nordisk
Neomorph
AbbVie
Umoja Biopharma
Merck KGaA
Caris Life Sciences
Voyager Therapeutics
Boehringer outlines up to $33.6m for cancer asset from OSE Therapeutics
Clinical Trials Arena
Thu, 05/23/24 - 09:43 pm
Boehringer Ingelheim
OSE Immunotherapeutics
oncology
Boehringer pays OSE $42M to expand collab into cardio disease, grab new asset
Fierce Biotech
Wed, 05/22/24 - 11:31 am
Boehringer Ingelheim
OSE Immunotherapeutics
cardiovascular disease
solid tumors
Boehringer, Walgreens Team Up for Obesity Trial as Weight-Loss Drug Race Heats Up
BioSpace
Mon, 05/6/24 - 11:33 am
Boehringer Ingelheim
Walgreens
obesity
type 2 diabetes
clinical trials
survodutide
FDA Approval Fuels Boehringer’s Biosimilar Challenge to AbbVie’s Humira
BioSpace
Thu, 05/2/24 - 11:37 am
Boehringer Ingelheim
Cyltezo
AbbVie
Huira
FDA
biosimilars
Boehringer signs $1.3B deal with RNA biotech Ochre Bio to team up against MASH
Fierce Biotech
Mon, 04/22/24 - 11:44 am
Boehringer Ingelheim
Ochre Bio
RNA
MASH
NASH
Jardiance doesn’t cut it in post-heart attack trial
Pharmaphorum
Mon, 04/8/24 - 11:21 am
Boehringer Ingelheim
Eli Lilly
Jardiance
clinical trials
heart attack
Boehringer to lay off salespeople as Humira biosimilar sales lag
Reuters
Fri, 04/5/24 - 11:33 am
Boehringer Ingelheim
AbbVie
Humira
biosimilars
layoffs
GSK joins AstraZeneca, Boehringer in capping US out-of-pocket inhaler prices at $35 per month
Fierce Pharma
Thu, 03/21/24 - 06:37 pm
GSK
Boehringer Ingelheim
AstraZeneca
drug pricing
COPD
asthma
AstraZeneca follows rival Boehringer in capping out-of-pocket costs for inhalers
Reuters
Mon, 03/18/24 - 11:05 am
AstraZeneca
inhalers
drug pricing
Boehringer Ingelheim
Airsupra
Bevespi Aerosphere
Breztri Aerosphere
COPD
Asgard Gets $32M Series A Backing from J&J, Novo and Boehringer
BioSpace
Sun, 03/17/24 - 09:25 pm
Asgard Therapeutics
JNJ
Novo Nordisk
Boehringer Ingelheim
funding
immuno-oncology
Boehringer licenses Sosei schizophrenia drugs in €755m deal
Pharmaphorum
Mon, 03/11/24 - 11:40 am
Boehringer Ingelheim
schizophrenia
Sosei
Boehringer to cap out-of-pocket inhaler cost at $35 per month
Reuters
Thu, 03/7/24 - 11:08 am
Boehringer Ingelheim
drug pricing
Atrovent
Combivent Respimat
Spiriva HandiHale
COPD
Boehringer’s survodutide shows monster MASH potential
Pharmaphorum
Mon, 02/26/24 - 10:36 am
Boehringer Ingelheim
weight loss
MASH
NASH
survodutide
Notable Labs hopes for success with Boehringer’s failed AML drug
Clinical Trials Arena
Fri, 02/23/24 - 10:35 am
Notable Labs
Boehringer Ingelheim
AML
volasertib
artificial intelligence
Boehringer Ingelheim pledges €120M to expand Greek plant, add capacity for Jardiance
Fierce Pharma
Fri, 01/12/24 - 09:55 am
Boehringer Ingelheim
drug manufacturing
Greece
Jardiance
Most extensive cirrhosis £30M study funded by Boehringer Ingelheim
Outsourcing Pharma
Mon, 01/8/24 - 11:26 am
Boehringer Ingelheim
liver cirrhosis
funding
Beleaguered Theravance logs head-to-head trial loss for Yupelri against Boehringer's Spiriva
Fierce Pharma
Sun, 01/7/24 - 04:07 pm
Theravance
Yupelri
COPD
Boehringer Ingelheim
Spiriva
Boehringer bets $2B in biobucks to unlock siRNA targets for NASH treatments
Fierce Biotech
Wed, 01/3/24 - 09:40 am
Boehringer Ingelheim
biobucks
NASH
siRNA
Suzhou Ribo
Ribocure

Pages